A cоmpаny mаrkets а cоsmetic skin cream in Sоuth Africa and advertises it as "able to cure eczema permanently and heal all skin infections without medical treatment." After complaints from consumers who experienced skin irritation, regulators investigate the product. Which legislation(s) may apply in this situation, given both the product's classification and its misleading therapeutic claims?